Previous 10 | Next 10 |
Dexcom unveils more clinical data reaffirming the benefits of Dexcom CGM use among people with Type 2 diabetes than at any previous ADA conference. ADA conference presentations reiterate the advantages of Dexcom CGM use alongside incretin therapies such as GLP-1s. 1,2 New Dexc...
2024-06-10 08:50:03 ET Abbott Laboratories: Why I Agree With Wall Street On This One Abbott Laboratories: Buying More Of This Top-Notch Dividend Growth Stock Why I Believe Abbott Is Much Better Positioned In Today's Rising Inflation Scenario Tudor Investment's to...
2024-06-07 12:00:00 ET Summary In May, we had another twenty-four new analysts join us with their first idea on the site. Some companies covered in this edition: Target, JAKKS Pacific, Li Auto, Qudian, Pfizer, Dexcom, UnitedHealth Group, Verano, and more! Take a look for new a...
2024-06-05 11:21:33 ET More on iShares U.S. Medical Devices ETF: IHI: Technological Advances Will Continue Carrying This High-Performing Medical ETF Don't expect pandemic backlog to fuel orthopedic sales, says Needham Seeking Alpha’s Quant Rating on iShares U....
Diabetes management goes hands-free as Dexcom G7 now connects directly to Apple Watch * in the U.S., giving users confidence even when their iPhone isn’t with them † As the first and only CGM system that connects directly to Apple Watch, * Dexcom G7 gives users t...
2024-06-04 11:30:03 ET Bernstein analyst issues OUTPERFORM recommendation for DXCM on June 4, 2024 09:14AM ET. The previous analyst recommendation was Outperform. DXCM was trading at $115.76 at issue of the analyst recommendation. The overall analyst consensus : BUY. ...
DexCom, Inc. (Nasdaq: DXCM), a global leader in real-time continuous glucose monitoring for people with diabetes, today announced a significant advancement in access to its products for those treating Type 2 diabetes (T2D) with basal insulin injections. The company, which pioneered CGM technolo...
Nova Scotia becomes the latest province and territory to offer access to simple and easy-to-use diabetes management solutions, helping Canadians living with diabetes take control of their health Dexcom, Inc. (NASDAQ: DXCM), a global leader in real-time continuous glucose monitoring (rtC...
2024-06-03 07:45:00 ET Every good thing must come to an end -- and, eventually, the bull market we're experiencing will, too. Long-term investors must prepare for that to happen at some point. One of the best ways to do so is to buy stocks that can perform well through bull runs but can...
2024-06-01 08:00:00 ET More on the retail sector Retail Sector Earnings Roundup: Analyzing The Winners And Losers The consumer 'remains more likely to cruise' than crumble - Goldman Sachs Winners and losers from the latest retail sales report Seeking Alpha...
News, Short Squeeze, Breakout and More Instantly...
2024-07-04 10:00:00 ET Growth-oriented investors have experienced a bit of a roller-coaster ride over the past few years. Many companies in the "growth stock" category were struggling just two years ago, but in the bull market we are now experiencing, they're delivering very different resul...
DexCom, Inc. (NASDAQ:DXCM) today announced that it plans to release its second quarter 2024 financial results after market close on Thursday, July 25, 2024. Management will hold a conference call to review the company's second quarter 2024 performance starting at 4:30 p.m. (Eastern Time) on the...